Rein Therapeutics (RNTX) Preferred Dividend Payments (2016 - 2017)
Rein Therapeutics (RNTX) posted quarterly Preferred Dividend Payments of $21000.0 for Q2 2017, up 10.53% year-over-year from $19000.0 in Q2 2016, and up 5.0% quarter-over-quarter from $20000.0 in Q1 2017.
Rein Therapeutics (RNTX) Preferred Dividend Payments (2016 - 2017) Analysis & Trends
Rein Therapeutics (RNTX) has reported Preferred Dividend Payments for 2 consecutive years, with $21000.0 the latest figure, recorded in Q2 2017.
- In Q2 2017, Preferred Dividend Payments rose 10.53% year-over-year to $21000.0; the TTM figure through Dec 2017 stood at $41000.0 (down 45.33% YoY), while the FY2017 annual figure was $41000.0, down 45.33% from the prior year.
- Preferred Dividend Payments climbed to $21000.0 in Q2 2017 per RNTX's latest filing, from $20000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $21000.0 in Q2 2017 and bottomed at $18000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rein Therapeutics | 55.49 Mn | 55.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 21,000.00 |
| Mar 31, 2017 | 20,000.00 |
| Dec 31, 2016 | 19,000.00 |
| Sep 30, 2016 | 19,000.00 |
| Jun 30, 2016 | 19,000.00 |
| Mar 31, 2016 | 18,000.00 |